Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Relay Therapeutics Q3 EPS $(0.66) Misses $(0.64) Estimate

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 78 percent increase over losses of $(3.00) per share from
byBenzinga Newsdesk
November 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.64) by 3.13 percent. This is a 78 percent increase over losses of $(3.00) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts